PATENT CLAIM ANALYSIS

Application Number: 16046254
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-07
Patent Classification: ["514", "210160"]

Abstract:
Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, compositions thereof, and methods of their use.

Claim (Index 44):
A method for treating a condition or disorder mediated by at least one histone deacetylase in a patient in need thereof comprising administering to said patient a therapeutically effective amount of a compound according to  claim 1 , or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 95.0
- Lexical Diversity: 1.1
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15148907', '15148884', '15041375', '13522044', '15630200']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7908010495260421
- 35 USC 102 Novelty (BERT): 0.5527837524864695
- Combined Prediction Score: 0.7669993198220849
- Mean Citation Score: 371.179274
- Max Citation Score: 437.58426
- Similarity Product: 321.4150245451033

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test